Coastline Trust’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Coastline Trust’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,400	Closed	-$272K	–	316
2022 Q3	$272K	Hold	4,400	–	–	0.04%	268
2022 Q2	$351K	Hold	4,400	–	–	0.05%	262
2022 Q1	$463K	Hold	4,400	–	–	0.06%	250
2021 Q4	$474K	Hold	4,400	–	–	0.05%	250
2021 Q3	$482K	Hold	4,400	–	–	0.06%	246
2021 Q2	$412K	Hold	4,400	–	–	0.05%	254
2021 Q1	$405K	Hold	4,400	–	–	0.05%	253
2020 Q4	$322K	Buy	+4,400	New	+$327K	0.04%	274

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Coastline Trust's HZNP Position: Q4 2022 in Review

Coastline Trust sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022, closing a stake of 4,400 shares — an estimated $272K sold.

Coastline Trust first reported a position in HZNP in Q4 2020 and held it in 8 quarters. The position peaked at $482K in Q3 2021. 613 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

Coastline Trust reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Coastline Trust sold 4,400 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $272K.
Coastline Trust first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 8 quarters.
Coastline Trust's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $482K in Q3 2021.
613 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Coastline Trust's 13F filing for Q4 2022, filed 9 Feb 2023.